The proportions of people living with HIV in low and middle-income countries who test tuberculin skin test positive using either a 5 mm or a 10 mm cut-off: A systematic review

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Kerkhoff, Andrew D ^a,b   Gupta, Ankur ^c   Samandari, Taraz ^d   Lawn, Stephen D ^b,c  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

CD4; HIV; TST; Tuberculin skin test; Tuberculosis

Indexed keywords

AFRICA SOUTH OF THE SAHARA; ARTICLE; ASIA; CD4 LYMPHOCYTE COUNT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; PEOPLE LIVING WITH HIV; REFERENCE VALUE; SKIN INDURATION; SOCIOECONOMICS; SYSTEMATIC REVIEW; TUBERCULIN TEST; TUBERCULOSIS; UNITED STATES;

ADULT; HIV INFECTIONS; HUMANS; SOCIOECONOMIC FACTORS; TUBERCULIN TEST; TUBERCULOSIS; YOUNG ADULT;

EID: 84879813336     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-307     Document Type: Article

References (43)

1. World Health Organization Use of tuberculosis interferon-gamma release assays (IGRAs) in low- and middle- income countries 2011, 1-70. Geneva, Switzerland: World Health Organization, World Health Organization.
2. Sarrazin H, Wilkinson KA, Andersson J, Rangaka MX, Radler L, Van Veen K, Lange C, Wilkinson RJ. Association between tuberculin skin test reactivity, the memory CD4 cell subset, and circulating FoxP3-expressing cells in HIV-infected persons. J Infect Dis 2009, 199:702-710. 10.1086/596735, 19199536.
3. Centers for Disease Control and Prevention Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR 2000, 49(RR6):1-51. Centers for Disease Control and Prevention.
4. Centers for Disease Control (CDC) Tuberculosis and human immunodeficiency virus infection: recommendations of the Advisory Committee for the Elimination of Tuberculosis (ACET). MMWR 1989, 38:236-8-243-50. Centers for Disease Control (CDC).
5. Cobelens FG, Egwaga SM, Van Ginkel T, Muwinge H, Matee MI, Borgdorff MW. Tuberculin skin testing in patients with HIV infection: limited benefit of reduced cutoff values. Clin Infect Dis 2006, 43:634-639. 10.1086/506432, 16886159.
6. Kerkhoff AD, Kranzer K, Samandari T, Nakiyingi-Miiro J, Whalen CC, Harries AD, Lawn SD. Systematic review of TST responses in people living with HIV in under-resourced settings: implications for isoniazid preventive therapy. PLoS One 2012, 7:e49928. 10.1371/journal.pone.0049928, 3507950, 23209621.
7. World Bank Website 2011, Available: http://data.worldbank.org/about/country-classifications/country-and-lending-groups, World Bank Website.
8. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statist Med 2002, 21:1539-1558.
9. Allen S, Batungwanayo J, Kerlikowske K, Lifson AR, Wolf W, Granich R, Taelman H, Van De Perre P, Serufilira A, Bogaerts J. Two-year incidence of tuberculosis in cohorts of HIV-infected and uninfected urban Rwandan women. Am Rev Respir Dis 1992, 146:1439-1444. 10.1164/ajrccm/146.6.1439, 1456559.
10. Aisu T, Raviglione MC, Van Praag E, Eriki P, Narain JP, Barugahare L, Tembo G, McFarland D, Engwau FA. Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre. AIDS 1995, 9:267-273.
11. Duncan LE, Elliott AM, Hayes RJ, Hira SK, Tembo G, Mumba GT, Ebrahim SH, Quigley M, Pobee JO, McAdam KP. Tuberculin sensitivity and HIV-1 status of patients attending a sexually transmitted diseases clinic in Lusaka, Zambia: a cross-sectional study. Trans R Soc Trop Med Hyg 1995, 89:37-40. 10.1016/0035-9203(95)90649-5, 7747304.
12. Fordham Von Reyn C, Arbeit RD, Tosteson AN, Ristola MA, Barber TW, Waddell R, Sox CH, Brindle RJ, Gilks CF, Ranki A, Bartholomew C, Edwards J, Falkinham JO, O'Connor GT. The international epidemiology of disseminated Mycobacterium avium complex infection in AIDS. International MAC Study Group. AIDS 1996, 10:1025-1032. 10.1097/00002030-199610090-00014, 8853737.
13. Diagbouga S, Fumoux F, Ledru E, Sanou PT, Barro D, Marchal G. Lack of direct correlation between CD4 T-lymphocyte counts and induration sizes of the tuberculin skin test in human immunodeficiency virus type 1 seropositive patients. Int J Tuberc Lung Dis 1998, 2:317-323.
14. Waddell RD, Von CF R, Baboo KS, Mwinga A, Chintu C, Zumla A. The effects of BCG immunization and human immunodeficiency virus infection on dual skin test reactions to purified protein derivative and Mycobacterium avium sensitin among adults in Zambia. Int J Tuberc Lung Dis 1999, 3:255-260.
15. Mtei L, Matee M, Herfort O, Bakari M, Horsburgh CR, Waddell R, Cole BF, Vuola JM, Tvaroha S, Kreiswirth B, Pallangyo K, Reyn Von CF. High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania. Clin Infect Dis 2005, 40:1500-1507. 10.1086/429825, 15844073.
16. Tegbaru B, Wolday D, Messele T, Legesse M, Mekonnen Y, Miedema F, van Baarle D. Tuberculin skin test conversion and reactivity rates among adults with and without human immunodeficiency virus in urban settings in Ethiopia. Clin Vaccine Immunol 2006, 13:784-789. 10.1128/CVI.00098-06, 1489564, 16829616.
17. Rangaka MX, Diwakar L, Seldon R, Van Cutsem G, Meintjes GA, Morroni C, Mouton P, Shey MS, Maartens G, Wilkinson KA, Wilkinson RJ. Clinical, immunological, and epidemiological importance of antituberculosis T cell responses in HIV-infected Africans. Clin Infect Dis 2007, 44:1639-1646. 10.1086/518234, 17516410.
18. Karam F, Mbow F, Fletcher H, Senghor CS, Coulibaly KD, Lefevre AM, Ngom Gueye NF, Dieye T, Sow PS, Mboup S, Lienhardt C. Sensitivity of IFN-γ release assay to detect latent tuberculosis infection is retained in HIV-infected patients but dependent on HIV/AIDS progression. PLoS One 2008, 3:e1441. 10.1371/journal.pone.0001441, 2174527, 18197251.
19. Hanifa Y, Grant AD, Lewis J, Corbett EL, Fielding K, Churchyard G. Prevalence of latent tuberculosis infection among gold miners in South Africa. Int J Tuberc Lung Dis 2009, 13:39-46.
20. Leidl L, Mayanja-Kizza H, Sotgiu G, Baseke J, Ernst M, Hirsch C, Goletti D, Toossi Z, Lange C. Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection. Eur Respir J 2010, 35:619-626. 10.1183/09031936.00045509, 19608590.
21. Oni T, Burke R, Tsekela R, Bangani N, Seldon R, Gideon HP, Wood K, Wilkinson KA, Ottenhoff THM, Wilkinson RJ. High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening. Thorax 2011, 66:669-673. 10.1136/thx.2011.160168, 3142344, 21632522.
22. Samandari T, Agizew TB, Nyirenda S, Tedla Z, Sibanda T, Shang N, Mosimaneotsile B, Motsamai OI, Bozeman L, Davis MK, Talbot EA, Moeti TL, Moffat HJ, Kilmarx PH, Castro KG, Wells CD. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial. Lancet 2011, 377:1588-1598. 10.1016/S0140-6736(11)60204-3, 21492926.
23. Espinal MA, Reingold AL, Lavandera M. Effect of pregnancy on the risk of developing active tuberculosis. J Infect Dis 1996, 173:488-491. 10.1093/infdis/173.2.488, 8568319.
24. García-García ML, Valdespino-Gómez JL, García-Sancho C, Mayar-Maya ME, Palacios-Martínez M, Balandrano-Campos S, Escobar-Gutiérrez A, Peruga A, Weissenbacher M, Daniels E. Underestimation of Mycobacterium tuberculosis infection in HIV-infected subjects using reactivity to tuberculin and anergy panel. Int J Epidemiol 2000, 29:369-375. 10.1093/ije/29.2.369, 10817138.
25. Miranda A, Morgan M, Jamal L, Laserson K, Barreira D, Silva G, Santos J, Wells C, Paine P, Garrett D. Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001. PLoS One 2007, 2:e826. 10.1371/journal.pone.0000826, 1952142, 17786198.
26. Balcells ME, Pérez CM, Chanqueo L, Lasso M, Villanueva M, Espinoza M, Villarroel L, García P. A comparative study of two different methods for the detection of latent tuberculosis in HIV-positive individuals in Chile. Int J Infect Dis 2008, 12:645-652. 10.1016/j.ijid.2008.03.005, 18534887.
27. Gutierrez E, Gomes V, Picone C, Suga H, Atomiya A. Active tuberculosis and Mycobacterium tuberculosislatent infection in patients with HIV/AIDS. HIV Med 2009, 10:564-572. 10.1111/j.1468-1293.2009.00730.x, 19785665.
28. Baboolal S, Ramoutar D, Akpaka PE. Comparison of the QuantiFERON®-TB Gold assay and tuberculin skin test to detect latent tuberculosis infection among target groups in Trinidad & Tobago. Rev Panam Salud Publica 2010, 28:36-42.
29. Moura LC, Ximenes RA, Ramos HL, Filho DBM, Freitas CD, Silva RM, Coimbra I, Batista JDL, Montarroyos UR, Militão DFP, Albuquerque M. An evaluation of factors associated with taking and responding positive to the tuberculin skin test in individuals with HIV/AIDS. BMC Publ Health 2011, 11:687.
30. Suwanagool S, Chuenarom V, Pechthanon L, Sonjai A, Leelarasamee A, Pathrakom C. A comparative study of tuberculin skin test reactivity between asymptomatic HIV-1 seropositive subjects and healthy volunteers. Asian Pac J Allergy Immunol 1995, 13:139-144.
31. Yanai H, Uthaivoravit W, Mastro TD, Limpakarnjanarat K, Sawanpanyalert P, Morrow RH, Nieburg P. Utility of tuberculin and anergy skin testing in predicting tuberculosis infection in human immunodeficiency virus-infected persons in Thailand. Int J Tuberc Lung Dis 1997, 1:427-434.
32. Sawhney M, Sharma YK. Significance of tuberculin testing in HIV infection: An Indian perspective. Medical Journal Armed Forces India 2006, 62:104-107.
33. Gupta A, Nayak U, Ram M, Bhosale R, Patil S, Basavraj A, Kakrani A, Philip S, Desai D, Sastry J, Bollinger RC, Byramjee J. Medical College-Johns Hopkins University Study Group: Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005. Clin Infect Dis 2007, 45:241-249. 10.1086/518974, 17578786.
34. Swaminathan S, Subbaraman R, Venkatesan P, Subramanyam S, Kumar SR, Mayer KH, Narayanan PR. Tuberculin skin test results in HIV-infected patients in India: implications for latent tuberculosis treatment. Int J Tuberc Lung Dis 2008, 12:168-173.
35. Davarpanah M, Rasti M, Mehrabani D, Allahyari S, Neirami R, SaberiFiroozi M. Association between PPD and QuantiFERON gold TB test in TB infection and disease among HIV infected. Iran Red Crescent Med J 2009, 11:71-75.
36. Davarpanah M, Rafiee G, Mehrabani D. The prevalence of M. tuberculosis infection and disease in HIV positive individuals in Shiraz, Southern Iran. Iran Red Crescent Med J 2009, 11:199-202.
37. Jiang W, Shao L, Zhang Y, Zhang S, Meng C, Xu Y, Huang L, Wang Y, Wang Y, Weng X, Zhang W. High-sensitive and rapid detection of Mycobacterium tuberculosis infection by IFN-gamma release assay among HIV-infected individuals in BCG-vaccinated area. BMC Immunol 2009, 10:31. 10.1186/1471-2172-10-31, 2700818, 19476627.
38. Zhang M, Wang H, Liao M, Chen X, Graner M, Zhu X, Zhang J, Yang Q, Lu H, Zhou B, Chen X. Diagnosis of latent tuberculosis infection in bacille Calmette-Guérin vaccinated subjects in China by interferon-gamma ELISpot assay. Int J Tuberc Lung Dis 2010, 14:1556-1563.
39. Kabeer BSA, Sikhamani R, Raja A. Comparison of interferon gamma-inducible protein-10 and interferon gamma-based QuantiFERON TB Gold assays with tuberculin skin test in HIV-infected subjects. Diagn Microbiol Infect Dis 2011, 71:236-243. 10.1016/j.diagmicrobio.2011.07.012, 3193601, 21996360.
40. Nguyen DTM, Hung NQ, Giang LT, Dung NH, Lan NTN, Lan NN, Yen NTB, Bang ND, Ngoc DV, Trinh LTT, Beasley RP, Ford CE, Hwang L-Y, Graviss EA. Improving the diagnosis of pulmonary tuberculosis in HIV-infected individuals in Ho Chi Minh City, Viet Nam. Int J Tuberc Lung Dis 2011, 15:1528-1534. 10.5588/ijtld.10.0777, 22008768.
41. Rangaka MX, Wilkinson KA, Glynn JR, Ling D, Menzies D, Mwansa-Kambafwile J, Fielding K, Wilkinson RJ, Pai M. Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2012, 12:45-55. 10.1016/S1473-3099(11)70210-9, 3568693, 21846592.
42. World Health Organization Guidelines for intensified tuberculosis case-finding and isoniazid preventative therapy for people living with HIV in resource-contrained settings 2011, 1-187. World Health Organization.
43. Akolo C, Adetifa I, Shepperd S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev 2010, CD000171.